Hochschulschrift
HER2 dynamics and EGF-NRG1 shape the response of HER2-targeted therapies in breast cancer
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Maße
-
30 cm
- Umfang
-
159 Seiten
- Sprache
-
Englisch
- Anmerkungen
-
Illustrationen, Diagramme
Ruprecht-Karls-University Heidelberg, Dissertation, 2024
- Ereignis
-
Veröffentlichung
- (wo)
-
Heidelberg
- (wann)
-
[2024]
- Urheber
- Beteiligte Personen und Organisationen
- Inhaltsverzeichnis
- Rechteinformation
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Letzte Aktualisierung
-
11.06.2025, 14:16 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Hochschulschrift
Entstanden
- [2024]
Ähnliche Objekte (12)
Photoimmunotherapy of HER2-expressing Breast Cancer Cells
Depicting Biomarkers for HER2-Inhibitor Resistance: Implication for Therapy in HER2-Positive Breast Cancer
EGFR Expression in HER2-Driven Breast Cancer Cells
Exploring combination treatment with a HER2 and a Pirin inhibitor in HER2-overexpressing breast cancer cells
Quantification of EGFR-HER2 Heterodimers in HER2-Overexpressing Breast Cancer Cells Using Liquid-Phase Electron Microscopy
Biomarker potential of extracellular microRNA expression signatures in breast cancer under HER2-targeted therapy
Prognostic effect of HER2 evolution from primary breast cancer to breast cancer metastases
Häufigkeit der EGFR- und HER2-Ausprägung sowie HER2-Genamplifikation beim Gallengangskarzinom
Einfluss von HER2 auf EGF-Rezeptor-vermittelte Signaltransduktion und Migration in humanen Glioblastomzelllinien
Silencing of the HER2/neu gene by siRNA inhibits proliferation and induces apoptosis in HER2/neu-overexpressing breast cancer cells
Clinical Characteristics and Prognosis of HER2-0 and HER2-Low-Positive Breast Cancer Patients: Real-World Data from Patients Treated with Neoadjuvant Chemotherapy
Targeted Intraoperative Radiotherapy Tumour Bed Boost during Breast-Conserving Surgery after Neoadjuvant Chemotherapy - a Subgroup Analysis of Hormone Receptor-Positive HER2-Negative Breast Cancer
Photoimmunotherapy of HER2-expressing Breast Cancer Cells
Depicting Biomarkers for HER2-Inhibitor Resistance: Implication for Therapy in HER2-Positive Breast Cancer
EGFR Expression in HER2-Driven Breast Cancer Cells
Exploring combination treatment with a HER2 and a Pirin inhibitor in HER2-overexpressing breast cancer cells
Quantification of EGFR-HER2 Heterodimers in HER2-Overexpressing Breast Cancer Cells Using Liquid-Phase Electron Microscopy
Biomarker potential of extracellular microRNA expression signatures in breast cancer under HER2-targeted therapy
Prognostic effect of HER2 evolution from primary breast cancer to breast cancer metastases
Häufigkeit der EGFR- und HER2-Ausprägung sowie HER2-Genamplifikation beim Gallengangskarzinom
Einfluss von HER2 auf EGF-Rezeptor-vermittelte Signaltransduktion und Migration in humanen Glioblastomzelllinien
Silencing of the HER2/neu gene by siRNA inhibits proliferation and induces apoptosis in HER2/neu-overexpressing breast cancer cells
Clinical Characteristics and Prognosis of HER2-0 and HER2-Low-Positive Breast Cancer Patients: Real-World Data from Patients Treated with Neoadjuvant Chemotherapy
Targeted Intraoperative Radiotherapy Tumour Bed Boost during Breast-Conserving Surgery after Neoadjuvant Chemotherapy - a Subgroup Analysis of Hormone Receptor-Positive HER2-Negative Breast Cancer
Photoimmunotherapy of HER2-expressing Breast Cancer Cells
Depicting Biomarkers for HER2-Inhibitor Resistance: Implication for Therapy in HER2-Positive Breast Cancer
EGFR Expression in HER2-Driven Breast Cancer Cells
Exploring combination treatment with a HER2 and a Pirin inhibitor in HER2-overexpressing breast cancer cells
Quantification of EGFR-HER2 Heterodimers in HER2-Overexpressing Breast Cancer Cells Using Liquid-Phase Electron Microscopy
Biomarker potential of extracellular microRNA expression signatures in breast cancer under HER2-targeted therapy
Prognostic effect of HER2 evolution from primary breast cancer to breast cancer metastases
Häufigkeit der EGFR- und HER2-Ausprägung sowie HER2-Genamplifikation beim Gallengangskarzinom
Einfluss von HER2 auf EGF-Rezeptor-vermittelte Signaltransduktion und Migration in humanen Glioblastomzelllinien
Silencing of the HER2/neu gene by siRNA inhibits proliferation and induces apoptosis in HER2/neu-overexpressing breast cancer cells
Clinical Characteristics and Prognosis of HER2-0 and HER2-Low-Positive Breast Cancer Patients: Real-World Data from Patients Treated with Neoadjuvant Chemotherapy